Dover's Polonator Unaffected by Danaher's Restructuring, Official Says | GenomeWeb

This article was originally published Sept. 3.

By Julia Karow

Work on the Polonator, a second-generation sequencing system jointly developed by a group at Harvard Medical School and Dover, a Danaher Motion company, will be unaffected by a restructuring that Danaher announced last week, In Sequence has learned.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.